drugset / Trial / NCT06286059

Efficacy of Phentolamine in Prevention of Contrast-Associated Acute Kidney Injury After Complex PCI

NCT06286059

Phase 2/3 Unknown 60 enrolled Helwan University
RandomizedParallel-groupSingle-blindPrevention

Summary

To evaluate the efficacy and safety of phentolamine in prevention of CA-AKI following complex PCI in patients at high risk of CA-AKI.

Timeline

Start
2024-03-07
Primary completion
2024-12-31
Completion
2025-01-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Phentolamine Small molecule 2 ug/kg